Asthma: Symptoms, Causes, Treatments & Natural Approaches

About Asthma

Asthma (technically bronchial asthma) is a chronic inflammatory condition of the lower respiratory tract characterized by reversible airway obstruction, bronchial hyperresponsiveness, and airway remodeling. The bronchi and bronchioles — the conducting airways that branch from the trachea into the lungs — become inflamed at the mucosal surface and narrowed by smooth-muscle contraction of the airway walls.

The hallmark physiology involves three mechanisms acting together during an attack:

• Bronchoconstriction — the smooth muscle wrapping the bronchi tightens, mechanically narrowing the airway.
• Inflammation — the airway lining swells with inflammatory cells (eosinophils, mast cells, T-helper-2 lymphocytes) releasing histamine, leukotrienes, and cytokines.
• Mucus hypersecretion — goblet cells produce thick mucus that further obstructs the narrowed airways.

Asthma is classified by severity (intermittent, mild persistent, moderate persistent, severe persistent), by trigger pattern (allergic / atopic vs. non-allergic), and by clinical phenotype (exercise-induced, occupational, aspirin-exacerbated, eosinophilic, etc.). Most people with asthma have an underlying genetic predisposition combined with environmental triggers.

Symptoms

The classic symptoms of asthma reflect the underlying airway narrowing and inflammation:

• Wheezing — a high-pitched whistling sound on exhalation, sometimes audible at rest, often more pronounced during or after exercise
• Shortness of breath (dyspnea) — feeling unable to get enough air, especially with activity or at night
• Cough — often dry and worse at night or with cold air; in some people (cough-variant asthma) cough is the only symptom
• Chest tightness — a sensation of pressure or constriction in the chest
• Low oxygen saturation during attacks, sometimes leading to lightheadedness or fainting in severe episodes

Symptoms typically fluctuate over time, often worsening at night, in the early morning, with exposure to triggers (allergens, cold air, exercise, respiratory infections, smoke, fumes), or during respiratory illnesses. Between attacks, many people with well-controlled asthma have no symptoms at all.

Red flags requiring emergency care: severe shortness of breath with inability to speak in full sentences, blue or grey lips/fingertips (cyanosis), peak flow under 50%% of personal best, no improvement with rescue inhaler.

Tests & Diagnostics

Asthma is diagnosed clinically and confirmed with objective measurements of variable airway obstruction.

History and physical examination

The clinician evaluates symptom pattern, triggers, family history of asthma or atopy (eczema, allergic rhinitis), occupational and environmental exposures, and reviews response to past treatment trials. Physical exam may reveal wheezing on auscultation, prolonged expiratory phase, or signs of allergic disease.

Pulmonary function testing

• Spirometry — the primary diagnostic test, measuring FEV1 (forced expiratory volume in 1 second) and FVC (forced vital capacity); reversibility of obstruction after bronchodilator confirms asthma
• Peak expiratory flow rate (PEFR) — bedside measurement of maximum exhalation speed; useful for home monitoring and tracking treatment response
• Bronchoprovocation testing (methacholine or exercise challenge) — used when spirometry is normal but asthma is still suspected

Adjunctive testing

• Chest X-ray — typically normal in uncomplicated asthma but ordered to exclude pneumonia, foreign body, or structural causes
• Allergy testing — skin prick or specific IgE blood testing identifies allergic triggers
• FeNO (fractional exhaled nitric oxide) — measures eosinophilic airway inflammation, useful in steroid-responsive phenotype
• CBC with differential — eosinophilia supports allergic/eosinophilic asthma

Common tests: X-ray.

Conventional treatment summary

Conventional asthma treatment follows a stepwise approach defined by global guidelines (GINA, NIH), separating rescue therapy for acute symptoms from controller therapy for long-term management.

Rescue (quick-relief) therapy

For acute symptoms, the standard first-line treatment is a short-acting beta-2 agonist (SABA) bronchodilator — most commonly albuterol (salbutamol) via metered-dose inhaler or nebulizer. These work within minutes by relaxing airway smooth muscle.

Controller (long-term) therapy

For persistent asthma, daily controller medications reduce airway inflammation:

• Inhaled corticosteroids (ICS) — fluticasone, budesonide, beclomethasone, mometasone — the cornerstone of long-term control
• Long-acting beta-agonists (LABA) — combined with ICS, never used alone — salmeterol, formoterol
• Leukotriene receptor antagonists — montelukast, zafirlukast — oral, useful for allergic + exercise-induced patterns
• Inhaled cromolyn or nedocromil — mast-cell stabilizers, especially in pediatric and exercise-induced asthma
• Long-acting muscarinic antagonists (LAMA) — tiotropium — for moderate-severe cases
• Biologics — omalizumab (anti-IgE), mepolizumab/reslizumab/benralizumab (anti-IL-5), dupilumab (anti-IL-4Ralpha) — for severe asthma with specific phenotypes

Severe flare management

Acute severe asthma requires oral or intravenous corticosteroids (prednisone, methylprednisolone), supplemental oxygen, nebulized bronchodilators, and in life-threatening cases, magnesium sulfate IV, ventilator support, or ICU admission.

Trigger identification and avoidance, allergen immunotherapy (for allergic asthma), and patient education on inhaler technique are essential components of any treatment plan.

Medical specialties

Internal Medicine · Pediatrics · Pulmonology · Family Practice · Allergy and Immunology · Pediatric Pulmonology